Brachytherapy Improves Biochemical Failure–Free Survival in Low- and Intermediate-Risk Prostate Cancer Compared With Conventionally Fractionated External Beam Radiation Therapy: A Propensity Score Matched Analysis-Reference-Cited by-同舟云学术

Brachytherapy Improves Biochemical Failure–Free Survival in Low- and Intermediate-Risk Prostate Cancer Compared With Conventionally Fractionated External Beam Radiation Therapy: A Propensity Score Matched Analysis

Published:2015-03 Issue:3 Volume:91 Page:505-516
ISSN:0360-3016
Container-title:International Journal of Radiation Oncology*Biology*Physics
language:en
Short-container-title:International Journal of Radiation Oncology*Biology*Physics

Author:

Smith Graham D.,Pickles Tom,Crook Juanita,Martin Andre-Guy,Vigneault Eric,Cury Fabio L.,Morris Jim,Catton Charles,Lukka Himu,Warner Andrew,Yang Ying,Rodrigues George

Publisher

Elsevier BV

Subject

Cancer Research,Radiology Nuclear Medicine and imaging,Oncology,Radiation

Reference63 articles.

1. Treatment options for localized prostate cancer;Keyes;Can Fam Physician,2013

2. Controversies in prostate cancer radiotherapy: Consensus development;Lukka;Can J Urol,2001

3. Pre-treatment risk stratification of prostate cancer patients: A critical review;Rodrigues;Can Urol Assoc J,2012

4. Escalated-dose versus standard-dose conformal radiotherapy in prostate cancer: First results from the MRC RT01 randomized controlled trial;Dearnaley;Lancet Oncol,2007

5. Randomized pilot study of dose escalation using conformal radiotherapy in prostate cancer: Long-term follow-up;Creak;Br J Cancer,2013

Cited by 58 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Prostate high dose-rate brachytherapy as monotherapy for low and intermediate-risk prostate cancer: Efficacy results from a randomized phase II clinical trial of one fraction of 19 Gy or two fractions of 13.5 Gy: A 9-year update;Radiotherapy and Oncology;2024-09

2. Review of brachytherapy clinical trials: a cross-sectional analysis of ClinicalTrials.gov;Radiation Oncology;2024-02-13

3. Biosimilars in Prostate Cancer;Biosimilars for Cancer Treatment;2024

4. A Systematic Review of the Efficacy and Toxicity of Brachytherapy Boost Combined with External Beam Radiotherapy for Nonmetastatic Prostate Cancer;European Urology Oncology;2023-12

5. Gender Differences in Reserving Conservatism;North American Actuarial Journal;2023-10-23